BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 2014;5:221-230. [PMID: 24665346 DOI: 10.7150/jca.7691] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther 2016;9:6297-304. [PMID: 27785077 DOI: 10.2147/OTT.S110295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Yang WE, Hsieh MJ, Lin CW, Kuo CY, Yang SF, Chuang CY, Chen MK. Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression. Int J Med Sci 2017;14:1094-100. [PMID: 29104463 DOI: 10.7150/ijms.20414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
3 Ustyol A, Aycan Ustyol E, Gurdol F, Kokali F, Bekpınar S. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 2017;77:205-9. [DOI: 10.1080/00365513.2017.1292363] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
4 Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Temel Yuksel I, Toprak MS, Ekmekci H, Balci Ekmekci O, Madazli R. Serum endocan concentration in women with pre-eclampsia. Arch Gynecol Obstet 2015;292:69-73. [PMID: 25534164 DOI: 10.1007/s00404-014-3605-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
5 Gök M, Kundi H, Kiziltunç E, Topçuoğlu C, Örnek E. The relationship between serum endocan levels and the presence/severity of isolated coronary artery ectasia. Cardiovasc Endocrinol Metab 2018;7:42-6. [PMID: 31646279 DOI: 10.1097/XCE.0000000000000143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kupeli I, Salcan S, Kuzucu M, Kuyrukluyıldız U. Can endocan be a new biomarker in ventilator-associated pneumonia? The Kaohsiung Journal of Medical Sciences 2018;34:689-94. [DOI: 10.1016/j.kjms.2018.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kundi H, Balun A, Cicekcioglu H, Karayigit O, Topcuoglu C, Kilinckaya MF, Kiziltunc E, Cetin M, Ornek E. Admission Endocan Level may be a Useful Predictor for In-Hospital Mortality and Coronary Severity Index in Patients With ST-Segment Elevation Myocardial Infarction. Angiology 2017;68:46-51. [DOI: 10.1177/0003319716646932] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
8 Toshikuni N, Ozaki K, George J, Tsutsumi M. Serum endocan as a survival predictor for patients with liver cirrhosis. Can J Gastroenterol Hepatol 2015;29:427-30. [PMID: 26669300 DOI: 10.1155/2015/153805] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Qiu C, Fu Q, Sui J, Zhang Q, Wei P, Wu Y, Zhu K, Lu Y, Zong B. Serum Endothelial Cell–Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance: A Pilot Study. Angiology 2017;68:354-9. [DOI: 10.1177/0003319716651349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
10 Erman H, Beydogan E, Cetin SI, Boyuk B. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Mediators Inflamm 2020;2020:3534042. [PMID: 32317862 DOI: 10.1155/2020/3534042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li P, Huang W, Wang F, Ke YF, Gao L, Shi KQ, Zhou MT, Chen BC. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma. Biosci Rep. 2018;38. [PMID: 30254101 DOI: 10.1042/bsr20180464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Iacovazzo D, Chiloiro S, Carlsen E, Bianchi A, Giampietro A, Tartaglione T, Bima C, Bracaccia ME, Lugli F, Lauretti L, Anile C, Gessi M, Colosimo C, Rindi G, Pontecorvi A, Korbonits M, De Marinis L. Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours. Endocrine 2020;67:651-8. [PMID: 31875303 DOI: 10.1007/s12020-019-02145-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Lee HG, Choi HY, Bae JS. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease. Kidney Int 2014;86:1079-81. [PMID: 25427083 DOI: 10.1038/ki.2014.292] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
14 Sumei Z, Shaolong C, Xiang W, Yinliang Q, Qing Z, Yuan W. Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression. Tumour Biol 2016;37:14915-21. [PMID: 27644250 DOI: 10.1007/s13277-016-5398-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gok M, Kundi H, Kiziltunc E, Topcuoglu C, Ornek E. Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study. Angiology 2018;69:43-8. [PMID: 28393589 DOI: 10.1177/0003319717703835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Youssef AA, Issa HA, Omar MZ, Behiry EG, Elfallah AA, Hasaneen A, Darwish M, Ibrahim DB. Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality. Clin Exp Gastroenterol 2018;11:431-8. [PMID: 30538523 DOI: 10.2147/CEG.S171339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kim KH, Lee HH, Yoon YE, Na JC, Kim SY, Cho YI, Hong SJ, Han WK. Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma. Oncotarget 2018;9:662-7. [PMID: 29416643 DOI: 10.18632/oncotarget.23087] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Basim P, Argun D. A Comparison of the Circulating Endocan Levels between the Inflammatory and Malignant Diseases of the Same Organ: The Breast. Journal of Investigative Surgery. [DOI: 10.1080/08941939.2020.1792008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Wang X, Yang W, Luo T, Wang J, Jing Y. Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension. Genetic Testing and Molecular Biomarkers 2015;19:124-7. [DOI: 10.1089/gtmb.2014.0274] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
20 Chen J, Zhao J, Ma R, Lin H, Liang X, Cai X. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis. PLoS One. 2014;9:e103952. [PMID: 25093414 DOI: 10.1371/journal.pone.0103952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
21 Arslan B, Onuk Ö, Hazar İ, Aydın M, Çilesiz NC, Eroglu A, Nuhoglu B. Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy. Tumori 2017;103:204-8. [DOI: 10.5301/tj.5000535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Laloglu E, Aksoy H, Aksoy Y, Ozkaya F, Akcay F. The determination of serum and urinary endocan concentrations in patients with bladder cancer. Ann Clin Biochem 2016;53:647-53. [PMID: 26748103 DOI: 10.1177/0004563216629169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
23 Li Q, Liu X, Gu J, Zhu J, Wei Z, Huang H. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis. Mol Genet Genomic Med 2020;8:e1512. [PMID: 33002344 DOI: 10.1002/mgg3.1512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kul S, Caklili OT, Tutuncu Y, Ozcan FB, Aksu F, Baycan OF, Atici A, Bilgili UZ, Takir M, Caliskan M. Endothelial dysfunction in patients with acromegaly and It's association with Endocan. Growth Horm IGF Res. 2021;56:101362. [PMID: 33221710 DOI: 10.1016/j.ghir.2020.101362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Pan KF, Yang YC, Lee WJ, Hua KT, Chien MH. Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188672. [PMID: 34953930 DOI: 10.1016/j.bbcan.2021.188672] [Reference Citation Analysis]
26 Baghy K, Tátrai P, Regős E, Kovalszky I. Proteoglycans in liver cancer. World J Gastroenterol 2016; 22(1): 379-393 [PMID: 26755884 DOI: 10.3748/wjg.v22.i1.379] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
27 Orbegozo D, Rahmania L, Irazabal M, Mendoza M, Annoni F, De Backer D, Creteur J, Vincent JL. Endocan as an early biomarker of severity in patients with acute respiratory distress syndrome. Ann Intensive Care 2017;7:93. [PMID: 28884313 DOI: 10.1186/s13613-017-0311-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
28 Li C, Geng H, Ji L, Ma X, Yin Q, Xiong H. ESM-1: A Novel Tumor Biomaker and its Research Advances. ACAMC 2019;19:1687-94. [DOI: 10.2174/1871520619666190705151542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Kundi H, Gok M, Kiziltunc E, Topcuoglu C, Cetin M, Cicekcioglu H, Ugurlu B, Ulusoy FV. The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow: A Cross-Sectional Study. Clin Appl Thromb Hemost 2017;23:472-7. [PMID: 26607436 DOI: 10.1177/1076029615618024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
30 Tanriverdi T, Kemerdere R, Inal BB, Yuksel O, Emre HO, Ahmedov M, Baran O, Ates S. Serum endocan levels before and after surgery on low-grade gliomas. Surg Neurol Int 2017;8:32. [PMID: 28458946 DOI: 10.4103/sni.sni_405_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Omar SA, Attia NM, Sheir MI, Amer AS, El Shabrawy MM, Hasan BB. Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation? Eur J Gastroenterol Hepatol 2021;33:1015-22. [PMID: 33867440 DOI: 10.1097/MEG.0000000000002074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Kara H, Karakulak UN, Gündüzöz M, Bal C, Alışık M, Büyükşekerci M, İritaş SB, Yılmaz ÖH, Tutkun L. Serum endocan level and diastolic functions in the case of lead exposure. Turk J Med Sci 2019;49:66-73. [PMID: 30761860 DOI: 10.3906/sag-1801-146] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Madhivathanan PR, Fletcher N, Gaze D, Thomson R, Chandrasekaran V, Al-Subaie N, Valencia O, Sharma V. Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass. Cytokine 2016;83:8-12. [PMID: 26999704 DOI: 10.1016/j.cyto.2016.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
34 Annan DA, Kikuchi H, Maishi N, Hida Y, Hida K. Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research. Int J Mol Sci 2020;21:E3238. [PMID: 32375250 DOI: 10.3390/ijms21093238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
35 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
36 Voiosu AM, Bălănescu P, Daha I, Smarandache B, Rădoi A, Mateescu RB, Băicuş CR, Voiosu TA. The diagnostic and prognostic value of serum endocan in patients with cirrhotic cardiomyopathy. Rom J Intern Med 2018;56:182-92. [PMID: 29453929 DOI: 10.2478/rjim-2018-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, Chaiworapongsa T. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med 2015;28:1621-32. [PMID: 25211383 DOI: 10.3109/14767058.2014.964676] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]